Greenstar Biosciences is entering the psychedelics space via its acquisition of Eleusian Biosciences Corp.
Psychedelics
Champignon Provides Corporate Update, Announces Name Change, Rebranding and Planned Spin Out
Champignon Brands is proposing changing its corporate name to Apotheosis Scientific Ltd, and announces a planned spin-off its consumer packaged goods (CPG) division.
Mydecine Innovations Group Adds a Leading Neuroscientist and a Psychopharmacology Specialist
Mydecine's new Scientific Advisor will work directly with the CSO in new drug development initiatives.
North Sur Resources and Mindset Pharma Announce Proposed Transaction to Accelerate Development of Medical Psychedelics Industry
An amalgamation of two private companies as psychedelics company Mindset Pharma Inc prepares to go public.
What Does Field Trip Psychedelics Offer Investors?
Field Trip Psychedelics has just announced a letter of intent to go public via RTO.
Mira X Acquisition Corp. Announces Proposed Qualifying Transaction with Field Trip Psychedelics Inc
Field Trip Psychedelics is planning to go public via a "three-cornered" RTO.
MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
Given that psychedelics micro-dosing has several commercial advantages, here are two companies that investors should look at.
Clarmin Explorations Inc. Enters Into Amalgamation Agreement for Reverse Takeover With Cybin Corp.
Cybin Corp will become the latest psychedelics company to go public, via RTO.
Psychedelics Investing 101: Basic Investing Tips
Psychedelic drugs are an emerging sector with exciting investment potential. Here are some tips on beginning your due diligence.
Empower to Open Wellness Clinic in Vancouver, Provides Updates on Its Psychedlics Division Dosed Wellness
Empower's new wellness clinic in Vancouver will support development of its psychedelics division.
Havn Life Sciences Inc. Announces Launch & Filing of Preliminary Prospectus
New psychedelics company specializing in psilocybin-based medical research has filed a prospectus.
Numinus Positioned To Be Significant Player In Psilocybin R&D
Numinus Wellness Inc. has assembled the licensing and personnel to be a significant player in psilocybin-based drug research.
MindMed Developing IP For Personalized Psychedelic Assisted Therapies
MindMed files patent applications for technologies to screen and optimize dosing of MDMA and LSD.
Why Psychedelics Micro-Dosing Applications Have The Inside Track On Commercialization
Psychedelics micro-dosing offers several key advantages over psychedelic drug applications centered around heavier dosages.
ATAI Life Sciences Forges Premier Psychedelics R&D Platform
ATAI Life Sciences is preparing to add three new drug development partners as it builds the premier R&D platform in the psychedelics space.